Global Intraocular Lenses Market 2018-2024: Strategic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
278
Global Intraocular Lenses Market 2018-2024: Strategic Business Report - Rising Need for Lenses with Multi-Distance Vision Capability

Dublin, July 05, 2018 (GLOBE NEWSWIRE) -- The "Intraocular Lenses - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets in US$ Thousand and Thousand Units by the following Segments:

  • Standard Intraocular Lenses
  • Premium Intraocular Lenses

The report profiles 29 companies including many key and niche players such as:

  • Alcon, Inc. (USA)
  • Bausch & Lomb, Inc. (USA)
  • Carl Zeiss Meditec AG (Germany)
  • Aaren Scientific, Inc. (USA)
  • EyeKon Medical, Inc. (USA)
  • Hoya Corporation (Japan)
  • Johnson & Johnson Vision Care, Inc. (USA)
  • Lenstec, Inc. (USA)
  • OcuLentis (Germany)
  • OPHTEC BV (Netherlands)
  • PhysIOL s.a. (Belgium)
  • Rayner Intraocular Lenses Limited (UK)
  • STAAR Surgical Company (USA)
  • The HumanOptics AG (Germany)

Key Topics Covered

1. INDUSTRY OVERVIEW Increasing Incidence of Vision Disorders: A Business Case for Ocular Products Intraocular Lenses (IOLs) Promise of Improved Vision Aids Market Growth Growth Drivers and Restraints In a Nutshell Driving Factors Restraining Factors Increasing Volume of Cataract Surgeries Opportunity for IOL Market Developed Countries Dominate with US Leading the Way in the Global IOLs Market Asia-Pacific to Spearhead Future Growth Premium Products Drive Revenue Growth Rising Need for Lenses with Multi-Distance Vision Capability Increase in IOL Implantations at Hospitals & Ambulatory Surgery Centers Rising Number of Cataract Surgeries in ASCs to Fuel Demand for IOLs Product-Level Market Dynamics Challenges Confronting IOL Market 2. COMPETITION A Peek into the Global IOL Competitive Landscape 3. MARKET DYNAMICS The Epic Transition from Non-foldable to Foldable Continues Growing Demand for Phacoemulsification Drives Adoption of Foldable Lenses Healthcare Spending and General Economy: Determinations of Growth in IOL Market Demographic Factors Influencing Growth in the IOL Market Dramatic Growth in Geriatric Population to Fuel Growth Burgeoning Global Population & Urbanization A Strong Business Case for Growth Rising Prevalence of Diabetes Fuels Growth Target Customer Groups & their Requirement Patterns Technological Innovations: A Boon to the IOL Industry Lasers: The High-Tech Solution Viscosurgery: A Safer Alternative Low Energy Methods for Cataract Removal Trifocal and Multifocal IOLs for Extended Depth of Focus Femtosecond Laser Heralds Next Generation of Refractive Surgery Product Innovations in Accommodative IOLs Pep-Up the Market PC-IOLs: Raising the Standard Accommodative IOLs or Multifocal IOLs The Tussle Carries On Post-Operative Refractive Errors: A Concern for Premium IOLs Adjustable IOLs Addressing Refractive Concerns of IOLs Debate Continues on Whether UV Protection is Essential in IOLs The Blue Light Saga US Lags Behind Europe in IOL Approvals Reimbursement Programs: The Key Determinant for Advanced IOLs IOL Reimbursement A Comparison between the US and European Systems 4. PRODUCT LANDSCAPE Multifocal IOLs Multifocal Lenses Bridging Gap between Conventional and Accommodative IOLs List of Select Approved and Under-Development Multifocal IOLs Overview of Select Multifocal IOLs ReSTOR (Alcon) Tecnis (Johnson & Johnson Vision Care) Tecnis Vs. ReSTOR A Comparison of ReSTOR and Tecnis Multifocal IOLs AcrySof IQ ReSTOR IOL Types Lentis MPlus (Oculentis) AT LISA (Carl Zeiss Meditec) FineVision (PhysIOL) Accommodative Intraocular lenses Mechanisms in Accommodative IOL Creation Accommodative Lenses and Their Need A Glance at Select Accommodative Intraocular Lenses List of Select Approved and Under-Development Accommodative IOLs Overview of Select Accommodative IOLs Crystalens (Bausch & Lomb) Tetraflex (Lenstec) FluidVision Lens (PowerVision) Assessing the Strengths of FluidVision DynaCurve (NuLens Ltd.) Tek-Clear IOL (Tekia) A Comparison of Crystalens and Tetraflex Accommodative IOLs Monofocal Lenses Introduction Monofocal Lenses Advantages and Disadvantages Advantages Disadvantages Europe Takes the Front Seat in Monofocal IOLs Toric IOLs Toric Intraocular Lenses Gaining Impetus Wide Power Range & Improved Surgical Procedures Drive Volumes of Toric Lenses Aspheric IOLs Aspheric Lenses Revolutionizing Vision Micro-Incision IOLs Evolution of Lens Material Various Materials Used in IOLs & their Characteristics Rigid PMMA acrylic Foldable Acrylics Silicone Elastomers Major Differentiating Characteristics Refractive Index Glass Transition Temperature Water Content Postoperative Calcification Glisterings 5. PRODUCT OVERVIEW 6. EFFECTS OF INTRAOCULAR LENSES IMPLANTATIONS Changes in the Size of Capsulorhexis Following IOL Implantation Effect of Anterior Chamber Baikoff Phakic IOLs on the Cornea Posterior Chamber IOL Fixed Sclerally for Children with Monocular Aphakia Aging of the Ciliary Sulcus on the Placement of Posterior Chamber IOLs Cystic Epithelial Downgrowth: A Complication of Intraocular Surgery Occurrence of Endophthalmitis After Secondary IOL Implantations Effect of Implantation of Silicone IOLs through Different Types of Incisions Width of the Anterior Capsule Opening After IOL Implantations Evaluation of the Cellular Reaction on the Surface of PMMA IOLs Incidence of Glaucoma in Children after Cataract Extraction & IOL Implantation Effect of Incision Length During IOL Implantation On Corneal Astigmatism Occurrence of Capsular Capture During Silicone IOL Implants Evaluation of the Anis Circular Lens Effect of Foldable Intraocular Lens Insertion On Incision Width Corneal Complications After Cataract & IOL Surgery Side Effects of Oval IOLs Implantation Effects of Phacoemulsification & Small-incision IOL Implantation on Incision Width Capsular Fibrotic Changes Suitable Lens After Cataract Surgery: Multifocal or Monofocal ? Aspheric IOL Improves Visual Performance 7. REGULATIONS GOVERNING THE PRODUCTION AND APPROVAL OF IOLS IOL Compressibility Test IOL Vault Testing Haptic Fatigue Testing Dardenne Testing Process of IOL Approval 8. PRODUCT INTRODUCTIONS/INNOVATIONS Bausch + Lomb Launches enVista MX60E IOL Alcon Unveils Clareon Intraocular Lens Rayner Introduces RayOne Aspheric and Spheric Monofocal Fully Preloaded IOL Injection Systems in Brazil Alcon Introduces AcrySof IQ ReSTOR +2.5 Multifocal Toric IOLs NIDEK Introduces SZ-1C Pre-Loaded IOL Injection System Alcon Unveils AcrySof IQ PanOptix Toric IOL Bausch + Lomb Introduces EZ-24 Easy-Load Lens Delivery System for SofPort Advanced Optics IOL Leica and TrueVision Launch IOLcompass Pro Rayner Launches Ophteis FR Pro Swiss Advanced Vision Rolls Out InFo Instant Focus IOL HumanOptics Launches ToricaDiff HumanOptics Introduces Aspira3P-aVA IOL Bausch + Lomb Launches Enhanced TRULIGN Toric Intraocular lens Calculator Bausch + Lomb Unveils Enhanced BLIS Injector System Abbott Introduces TECNIS Multifocal IOL in the US 9. RECENT INDUSTRY ACTIVITY Rayner Gains Indian CDSCO for RayOne Fully Preloaded IOL Injection System Alcon Gains CE Mark Approval for Preloaded Intraocular lens Delivery System Rayner Establishes US Subsidiary, Rayner Surgical HOYA Acquires Performance Optics OPHTEC Wins CE Mark for Precizon Presbyopic IOL Johnson & Johnson Acquires Abbott Medical Optics Calhoun Vision Changes Name to RxSight Rayner Gains CFDA Approval for Models in Sulcoflex Pseudophakic Supplementary IOLs Alcon Gains US FDA Approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL Rayner Takes Over Moorfields Pharmaceuticals Abbott Bags U.S. FDA Approval for Tecnis Symfony IOLs Rayner Creates Direct Presence in Italy through Rayner Italia Alcon and PowerVision Enter into Strategic Alliance for IOLs Bausch + Lomb to Distribute HOYA's IOLs and Injectors in the US Rayner Gains Approval for Selling IOLs in Egypt ClarVista Medical Secures Series B Financing Alcon Wins FDA Approval for AcrySof IQ ReSTOR +2.5 Diopter (D) IOL Rayner Gains KFDA Approval for Sulcoflex Toric IOL and T-flex Aspheric Toric IOL 10. FOCUS ON SELECT PLAYERS Alcon, Inc. (USA) Bausch & Lomb, Inc. (USA) Carl Zeiss Meditec AG (Germany) Aaren Scientific, Inc. (USA) EyeKon Medical, Inc. (USA) Hoya Corporation (Japan) Johnson & Johnson Vision Care, Inc. (USA) Lenstec, Inc. (USA) OcuLentis (Germany) OPHTEC BV (Netherlands) PhysIOL s.a. (Belgium) Rayner Intraocular Lenses Limited (UK) STAAR Surgical Company (USA) The HumanOptics AG (Germany) 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 29 (including Divisions/Subsidiaries 32)

  • The United States (17)
  • Canada (1)
  • Japan (2)
  • Europe (9)
    • France (1)
    • Germany (4)
    • The United Kingdom (1)
    • Rest of Europe (3)
  • Asia-Pacific (Excluding Japan) (2)
  • Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/d...lobal?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Optical

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading